About GenePath Diagnostics
GenePath Diagnostics is a company based in Pune (India) founded in 2008 by Nickhil Jakatdar and Nikhil Phadke. GenePath Diagnostics has raised $1.85 million across 6 funding rounds from investors including Saama Capital, Snow Leopard Global and Snow Leopard Ventures. GenePath Diagnostics offers products and services including Custom Reagents, STI Kits, UTI Assays, and Respiratory Tests. GenePath Diagnostics operates in a competitive market with competitors including Roche, Parse Biosciences, Biofidelity, RareCyte and Qiagen, among others.
- Headquarter Pune, India
- Founders Nickhil Jakatdar, Nikhil Phadke
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$724.84 (USD)-29as on Mar 31, 2024
-
Net Profit
-$483.22 (USD)75as on Mar 31, 2024
-
EBITDA
-$483.22 (USD)75as on Mar 31, 2024
-
Total Equity Funding
$1.85 M (USD)
in 6 rounds
-
Latest Funding Round
$336.88 K (USD), Grant
Nov 23, 2020
-
Investors
Saama Capital
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GenePath Diagnostics
GenePath Diagnostics offers a comprehensive portfolio of products and services, including Custom Reagents, STI Kits, UTI Assays, and Respiratory Tests.
Reagents for molecular testing in infectious diseases
Kits for sexually transmitted infection testing
Assays for urinary tract infection detection
Tests for respiratory and vector-borne diseases
People of GenePath Diagnostics
Unlock access to complete
Leadership Team
2 people
Operations Team
1 people
Finance and Accounting
1 people
Trinee Team
1 people
Sr. Team
1 people
Unlock access to complete
Funding Insights of GenePath Diagnostics
GenePath Diagnostics has successfully raised a total of $1.85M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $336.88 thousand completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in GenePath Diagnostics
GenePath Diagnostics has secured backing from 10 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Saama Capital, Snow Leopard Global and Snow Leopard Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments and partnerships in diverse sectors.
|
Locked | Locked | Locked | |
|
Investment management for public and private equity between India and the USA.
|
Locked | Locked | Locked | |
|
Early-stage venture capital firm investing in India
|
Locked | Locked | Locked |
Investor details for GenePath Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GenePath Diagnostics
Investment portfolio details for GenePath Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GenePath Diagnostics
Detailed financials for GenePath Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genepath Diagnostics Comparisons
Peer comparison for GenePath Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GenePath Diagnostics
GenePath Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Roche, Parse Biosciences, Biofidelity, RareCyte and Qiagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceuticals and diagnostics kits are developed for various diseases.
|
|
| Locked | Locked | Locked |
RNA-sequencing transcriptome kits for health data analysis are developed.
|
|
| Locked | Locked | Locked |
Molecular diagnostic assays are developed for target DNA sequence detection.
|
|
| Locked | Locked | Locked |
Developer of technologies for the analysis of rare and single cells in the blood
|
|
| Locked | Locked | Locked |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| Locked | Locked | Locked |
Developer of nucleic acid detection and quantification systems
|
Detailed competitors of GenePath Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genepath Diagnostics
Complete news archive for GenePath Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GenePath Diagnostics
GenePath Diagnostics was founded in 2008 and raised its 1st funding round 5 years after it was founded.
GenePath Diagnostics is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Nickhil Jakatdar is the current CEO of GenePath Diagnostics. They have also founded this company.
GenePath Diagnostics is a funded company, having raised a total of $1.85M across 6 funding rounds to date.
Annual revenue of GenePath Diagnostics is $724.84 as on Mar 31, 2024.
GenePath Diagnostics was founded in 2008 in Pune, India, as a provider of diagnostic solutions targeting infectious diseases, cancers, and genetic disorders. DNA and RNA-based tests are included in the portfolio, covering oncology, endocrinology, transplantation typing, hematology, pharmacogenetics, and pre-natal genetic testing. Detection services for HPV and COVID-19 infections are also handled, with operations focused on the biotechnology and healthcare sectors.
GenePath Diagnostics's top competitors include Roche, Qiagen and Parse Biosciences.
GenePath Diagnostics offers Custom Reagents, STI Kits, UTI Assays, and Respiratory Tests.
GenePath Diagnostics has 10 investors. Key investors include Saama Capital, Snow Leopard Global, Snow Leopard Ventures, Indo-U.S. Science and Technology Forum, and Prashant Mudgal.
The valuation of GenePath Diagnostics is $3.49M as of Feb 2016.